Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lorbeer

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Vision Research|January 1, 1976
Pseudo-tritan effect and the Vos-Walraven line element at low luminance levelsB Lorbeer, I Rentschler, R Röhler
Lancet (London, England)|October 27, 1984
Persistence of anti-HBs after intradermal inoculation of reduced doses of hepatitis B vaccineG Zoulek, B Lorbeer, W Jilg, et al.
Lancet (London, England)|March 10, 1984
Antibody responses and skin reactivity after intradermal hepatitis B virus vaccineG Zoulek, B Lorbeer, W Jilg, et al.
Journal of Medical Virology|January 1, 1984
Evaluation of a reduced dose of hepatitis B vaccine administered intradermallyG Zoulek, B Lorbeer, W Jilg, et al.
Journal of Virological Methods|January 1, 1987
Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV IIIL G Gürtler, J Eberle, B Lorbeer, et al.
Deutsche Medizinische Wochenschrift (1946)|April 11, 1986
[Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany]G Zoulek, L Gürtler, J Eberle, et al.
The Journal of Infection|July 1, 1983
Immune responses to active and passive-active vaccination against hepatitis BF Deinhardt, R Zachoval, W Jilg, et al.
The Journal of Infectious Diseases|July 1, 1984
Passive/active immunization against hepatitis BR Zachoval, W Jilg, B Lorbeer, et al.
Lancet (London, England)|November 24, 1984
Clinical evaluation of a recombinant hepatitis B vaccineW Jilg, B Lorbeer, M Schmidt, et al.
Journal of Hepatology|November 1, 1991
Long-term persistence of hepatitis C virus antibodies in a single source outbreakS Dittmann, M Roggendorf, J Dürkop, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Vision Research|January 1, 1976
Pseudo-tritan effect and the Vos-Walraven line element at low luminance levelsB Lorbeer, I Rentschler, R Röhler
Lancet (London, England)|October 27, 1984
Persistence of anti-HBs after intradermal inoculation of reduced doses of hepatitis B vaccineG Zoulek, B Lorbeer, W Jilg, et al.
Lancet (London, England)|March 10, 1984
Antibody responses and skin reactivity after intradermal hepatitis B virus vaccineG Zoulek, B Lorbeer, W Jilg, et al.
Journal of Medical Virology|January 1, 1984
Evaluation of a reduced dose of hepatitis B vaccine administered intradermallyG Zoulek, B Lorbeer, W Jilg, et al.
Journal of Virological Methods|January 1, 1987
Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV IIIL G Gürtler, J Eberle, B Lorbeer, et al.
Deutsche Medizinische Wochenschrift (1946)|April 11, 1986
[Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany]G Zoulek, L Gürtler, J Eberle, et al.
The Journal of Infection|July 1, 1983
Immune responses to active and passive-active vaccination against hepatitis BF Deinhardt, R Zachoval, W Jilg, et al.
The Journal of Infectious Diseases|July 1, 1984
Passive/active immunization against hepatitis BR Zachoval, W Jilg, B Lorbeer, et al.
Lancet (London, England)|November 24, 1984
Clinical evaluation of a recombinant hepatitis B vaccineW Jilg, B Lorbeer, M Schmidt, et al.
Journal of Hepatology|November 1, 1991
Long-term persistence of hepatitis C virus antibodies in a single source outbreakS Dittmann, M Roggendorf, J Dürkop, et al.
Pageof 2